R26C4H3P0T — CHP Retatrutide
Vendor COACHP | Retatrutide, last activity 1 month ago
5 related batch concerns
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 30 mg. Janoshik weighed 30.2 mg. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
20 units
on a U-100 insulin syringe, for 3 mg
- The vial holds dry powder: 30.2 mg of Retatrutide, as weighed.
- Water spreads that powder evenly through the liquid: 30.2 mg ÷ 2 ml = 15.1 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 151 mcg.
- Your dose divided by that: 3 mg ÷ 151 mcg = 20 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
same lot series
also CHP
Tirzepatide, same vendor
1 community mention, no summary yet
APS
An independent test found endotoxin at 1,437.86 EU/vial, far exceeding the 10 EU/vial working limit, while the vendor's…
Community Intelligence
- 1 concern report involving REPTN
- 2 concern reports involving 2026041210
- 4 concern reports involving XTP-R30-003
- 1 concern report involving JP20250821
- 1 concern report involving REPTN-1
Reported against other CHP Retatrutide batches, not this one.
Also known as: R26C4H3POT
Activity
No community activity tracked yet.
Vendor
CHP